loadpatents
name:-0.017408847808838
name:-0.084432125091553
name:-0.0019569396972656
RIVIER; Jean E. F. Patent Filings

RIVIER; Jean E. F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RIVIER; Jean E. F..The latest application filed is for "urocortin 2 analogs and uses thereof".

Company Profile
1.92.18
  • RIVIER; Jean E. F. - La Jolla CA
  • Rivier; Jean E. F. - LaJolla CA US
  • Rivier; Jean E F - La Jolla CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Urocortin 2 Analogs And Uses Thereof
App 20180271945 - VALE, JR.; Wylie W. ;   et al.
2018-09-27
Urocortin 2 analogs and uses thereof
Grant 9,572,866 - Vale, Jr. , et al. February 21, 2
2017-02-21
Urocortin-iii And Uses Thereof
App 20160375102 - VALE, JR.; Wylie W. ;   et al.
2016-12-29
Urocortin-III and uses thereof
Grant 9,388,229 - Vale, Jr. , et al. July 12, 2
2016-07-12
Urocortin 2 Analogs And Uses Thereof
App 20160022780 - VALE, JR.; Wylie W. ;   et al.
2016-01-28
Urocortin 2 Analogs And Uses Thereof
App 20150315257 - VALE, JR.; Wylie W. ;   et al.
2015-11-05
Cyclic CRF antagonist peptides
Grant 9,035,022 - Rivier May 19, 2
2015-05-19
Urocortin-iii And Uses Thereof
App 20140288161 - VALE, JR.; Wylie W. ;   et al.
2014-09-25
Somatostatin receptor 2 antagonists
Grant 8,691,761 - Rivier , et al. April 8, 2
2014-04-08
Urocortin-III and uses thereof
Grant 8,669,092 - Vale, Jr. , et al. March 11, 2
2014-03-11
Cyclic Crf Antagonist Peptides
App 20140024802 - Rivier; Jean E. F.
2014-01-23
Urocortin-iii And Uses Thereof
App 20140004603 - VALE, JR.; Wylie W. ;   et al.
2014-01-02
Receptor(SSTR2)-selective somatostatin antagonists
Grant 8,501,687 - Rivier , et al. August 6, 2
2013-08-06
Npy Antagonists
App 20120259092 - Chatenet; David ;   et al.
2012-10-11
Receptor(sstr2)-selective Somatostatin Antagonists
App 20110269683 - RIVIER; Jean E.F. ;   et al.
2011-11-03
Receptor(SSTR2)-selective somatostatin antagonists
Grant 7,960,342 - Rivier , et al. June 14, 2
2011-06-14
CRFR1 selective ligands
Grant 7,851,588 - Rivier , et al. December 14, 2
2010-12-14
Urocortin proteins and uses thereof
Grant 7,638,607 - Vale, Jr. , et al. December 29, 2
2009-12-29
Crfr1 Selective Ligands
App 20090149629 - Rivier; Jean E.F. ;   et al.
2009-06-11
CRFR1 selective ligands
Grant 7,498,300 - Rivier , et al. March 3, 2
2009-03-03
Somatostatin Receptor 2 Antagonists
App 20080299040 - RIVIER; Jean E. F. ;   et al.
2008-12-04
Receptor(sstr2)-selective Somatostatin Antagonists
App 20080260638 - Rivier; Jean E.F. ;   et al.
2008-10-23
Receptor(SSTR4)-selective somatostatin analogs
Grant 7,238,775 - Rivier , et al. July 3, 2
2007-07-03
Urocortin proteins and uses thereof
Grant 7,223,846 - Vale, Jr. , et al. May 29, 2
2007-05-29
CRFR2 selective ligands
Grant 7,141,546 - Rivier , et al. November 28, 2
2006-11-28
Conotoxins I
Grant RE39,240 - Olivera , et al. August 15, 2
2006-08-15
SSTR1-selective analogs
App 20060155107 - Rivier; Jean E.F. ;   et al.
2006-07-13
SSTR1-selective analogs
Grant 7,019,109 - Rivier , et al. March 28, 2
2006-03-28
Receptor(SSTR4)-selective somatostatin analogs
App 20050245438 - Rivier, Jean E. F. ;   et al.
2005-11-03
CRFR1 selective ligands
App 20040204564 - Rivier, Jean E.F. ;   et al.
2004-10-14
Peptides intermediates for making GnRH antagonists
Grant 6,747,125 - Hoeger , et al. June 8, 2
2004-06-08
Receptor-selective somatostatin analogs
Grant 6,579,967 - Rivier , et al. June 17, 2
2003-06-17
Urocortin peptides
App 20030032587 - Vale, Wylie W. JR. ;   et al.
2003-02-13
SSTR1-selective analogs
App 20020173618 - Rivier, Jean E.F. ;   et al.
2002-11-21
Cyclic CRF antagonist peptides
Grant 6,323,312 - Rivier November 27, 2
2001-11-27
Cyclic CRF agonists
Grant 5,824,771 - Rivier October 20, 1
1998-10-20
GNRH antagonist betides
Grant 5,807,983 - Jiang , et al. September 15, 1
1998-09-15
Receptor-selective somatostatin analogs
Grant 5,750,499 - Hoeger , et al. May 12, 1
1998-05-12
GnRH analogs
Grant 5,744,450 - Hoeger , et al. April 28, 1
1998-04-28
Amino acids and processes for making peptides using same
Grant 5,710,249 - Hoeger , et al. January 20, 1
1998-01-20
Conotoxins I
Grant 5,700,778 - Olivera , et al. December 23, 1
1997-12-23
GnRH analogs
Grant 5,580,957 - Hoeger , et al. December 3, 1
1996-12-03
Centrally truncated NPY cyclic peptides
Grant 5,569,742 - Kirby , et al. October 29, 1
1996-10-29
Peptides of melanin concentrating hormone precursor
Grant 5,530,095 - Vaughn , et al. June 25, 1
1996-06-25
GNRH antagonists XIII
Grant 5,506,207 - Rivier , et al. April 9, 1
1996-04-09
Cyclic CRF analogs
Grant 5,493,006 - de Miranda , et al. February 20, 1
1996-02-20
Conotoxins I
Grant 5,432,155 - Olivera , et al. July 11, 1
1995-07-11
Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins
Grant 5,371,070 - Koerber , et al. December 6, 1
1994-12-06
Amino acids useful in making GnRH analogs
Grant 5,352,796 - Hoeger , et al. October 4, 1
1994-10-04
GnRH analogs
Grant 5,296,468 - Hoeger , et al. March 22, 1
1994-03-22
CRF antagonists
Grant 5,245,009 - Kornreich , et al. * September 14, 1
1993-09-14
CRF analogs
Grant 5,235,036 - Kornreich , et al. August 10, 1
1993-08-10
Method of making peptides
Grant 5,169,935 - Hoeger , et al. December 8, 1
1992-12-08
GnRH analogs
Grant 5,169,932 - Hoeger , et al. December 8, 1
1992-12-08
CRF analog conjugates
Grant 5,132,111 - Vale, Jr. , et al. July 21, 1
1992-07-21
Cyclic GnRH antagonists
Grant 5,064,939 - Rivier , et al. November 12, 1
1991-11-12
Melanin-concentrating hormones
Grant 5,049,655 - Vaughan , et al. September 17, 1
1991-09-17
Cyclic GRF analogs
Grant 5,043,322 - Rivier , et al. August 27, 1
1991-08-27
Potentiation of erythropoiesis
Grant 5,032,507 - Yu , et al. July 16, 1
1991-07-16
NPY peptide analogs
Grant 5,026,685 - Boublik , et al. June 25, 1
1991-06-25
FSH-releasing peptides
Grant 4,973,577 - Vale, Jr. , et al. November 27, 1
1990-11-27
Antibodies to inhibin and conjugates produced therefrom
Grant 4,864,019 - Vale , et al. September 5, 1
1989-09-05
GRF analogs VI
Grant 4,784,987 - Rivier , et al. November 15, 1
1988-11-15
GnRH antagonists VIII
Grant 4,740,500 - Vale, Jr. , et al. April 26, 1
1988-04-26
Human inhibin
Grant 4,737,578 - Evans , et al. April 12, 1
1988-04-12
GRF analogs IIIb
Grant 4,728,726 - Rivier , et al. * March 1, 1
1988-03-01
Synthesis of N-substituted peptide amides
Grant 4,701,499 - Kornreich , et al. October 20, 1
1987-10-20
GnRH antagonists V
Grant 4,689,396 - Roeske , et al. * August 25, 1
1987-08-25
GnRH antagonists IX
Grant 4,661,472 - Rivier , et al. April 28, 1
1987-04-28
GnRH antagonists VII
Grant 4,652,550 - Rivier , et al. March 24, 1
1987-03-24
Hypothalamic GRF agonists
Grant 4,628,043 - Spiess , et al. December 9, 1
1986-12-09
GRF analogs II
Grant 4,626,523 - Vale, Jr. , et al. December 2, 1
1986-12-02
CRF antagonists
Grant 4,605,642 - Rivier , et al. August 12, 1
1986-08-12
Rat hypothalamic GRF
Grant 4,595,676 - Spiess , et al. June 17, 1
1986-06-17
GnRH Antagonists IV
Grant 4,569,927 - Rivier , et al. February 11, 1
1986-02-11
Synthesis of N-substituted peptide amides
Grant 4,569,967 - Kornreich , et al. February 11, 1
1986-02-11
GnRH Antagonists VI
Grant 4,565,804 - Rivier , et al. January 21, 1
1986-01-21
Human pancreatic GRF
Grant 4,563,352 - Rivier , et al. * January 7, 1
1986-01-07
Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
Grant 4,530,838 - Evans , et al. July 23, 1
1985-07-23
GRF Analogs
Grant 4,529,595 - Rivier , et al. July 16, 1
1985-07-16
GRF Analogs IV
Grant 4,528,190 - Vale, Jr. , et al. July 9, 1
1985-07-09
GRF Analogs III
Grant 4,518,586 - Rivier , et al. May 21, 1
1985-05-21
CCK Agonists II
Grant 4,490,364 - Rivier , et al. December 25, 1
1984-12-25
Treatment of male mammals
Grant 4,489,061 - Rivier , et al. * December 18, 1
1984-12-18
rCRF and analogs
Grant 4,489,163 - Rivier , et al. December 18, 1
1984-12-18
Conotoxins
Grant 4,447,356 - Olivera , et al. May 8, 1
1984-05-08
GnRH Antagonists II
Grant 4,444,759 - Rivier , et al. April 24, 1
1984-04-24
Analogs of somatostatin
Grant 4,428,942 - Rivier , et al. January 31, 1
1984-01-31
CRF And analogs
Grant 4,415,558 - Vale, Jr. , et al. November 15, 1
1983-11-15
GnRH antagonists
Grant 4,409,208 - Rivier , et al. * October 11, 1
1983-10-11
Analogs of extended N-terminal somatostatin
Grant 4,393,050 - Vale, Jr. , et al. July 12, 1
1983-07-12
Peptides affecting gonadal function
Grant 4,382,922 - Rivier , et al. May 10, 1
1983-05-10
Mobile phase for liquid chromatography
Grant 4,377,482 - Rivier March 22, 1
1983-03-22
Contraceptive treatment of male mammals
Grant 4,377,574 - Rivier , et al. March 22, 1
1983-03-22
Pharmaceutically active peptides
Grant 4,372,884 - Brown , et al. February 8, 1
1983-02-08
Bombesin analogs
Grant 4,331,661 - Marki , et al. May 25, 1
1982-05-25
LRF Antagonists
Grant 4,307,083 - Rivier , et al. December 22, 1
1981-12-22
Peptides which effect release of hormones
Grant RE30,548 - Vale, Jr. , et al. March 17, 1
1981-03-17
Water-soluble peptides affecting gonadal function
Grant 4,244,946 - Rivier , et al. January 13, 1
1981-01-13
Method for cyclization of peptides
Grant 4,216,141 - Rivier , et al. August 5, 1
1980-08-05
Peptides which inhibit gonadal function
Grant 4,215,038 - Rivier , et al. July 29, 1
1980-07-29
Peptides with para-substituted phenylalanine
Grant 4,211,693 - Rivier , et al. July 8, 1
1980-07-08
Peptides having analgesic and thermoregulative properties
Grant 4,207,311 - Brown , et al. June 10, 1
1980-06-10
Somatostatin analogs with dissociated biological activities
Grant 4,133,782 - Vale, Jr. , et al. January 9, 1
1979-01-09
Peptides which effect release of hormones
Grant 4,105,603 - Vale, Jr. , et al. August 8, 1
1978-08-08
Somatostatin and acylated des-(ala.sup.1, gly.sup.2) derivatives thereof
Grant 3,904,594 - Guillemin , et al. September 9, 1
1975-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed